Joseph R. Bertino, MD, is University Professor of medicine and pharmacology, UMDNJ-Robert Wood Johnson Medical School and has previously served as director of the Yale Cancer Center and chair of the Molecular Pharmacology and Therapeutics Program at Memorial Sloan-Kettering. He is the author and co-author of more than 400 scientific publications and the founding editor of the Journal of Clinical Oncology. His research is focused on curative treatments for leukemia and lymphoma and has helped shape optimal methotrexate administration schedules. Currently, his laboratory is studying gene therapy and stem cell research. He has received the Rosenthal Award from the American Association of Clinical Research, the Karnofsky Award from the American Society for Clinical Oncology, and the American Cancer Society Medal of Honor for his accomplishments in the field of research.